101 related articles for article (PubMed ID: 23969611)
1. Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated y-site administration.
Kupiec TC; Ben M; Trusley C; Trissel LA
Int J Pharm Compd; 2008; 12(2):170-3. PubMed ID: 23969611
[TBL] [Abstract][Full Text] [Related]
2. Compatibility and stability of palonosetron hydrochloride with four neruomuscular blocking agents during simulated y-site administration.
Trusley C; Ben M; Kupiec TC; Trissel LA
Int J Pharm Compd; 2008; 12(2):156-60. PubMed ID: 23969608
[TBL] [Abstract][Full Text] [Related]
3. Palonosetron hydrochloride compatiblity and stability with three B-lactam anitbiotic during simulated y-site adminstration.
Ben M; Trusley C; Kupiec TC; Trissel LA
Int J Pharm Compd; 2007; 11(6):520-4. PubMed ID: 23994813
[TBL] [Abstract][Full Text] [Related]
4. Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration.
Ben M; Kupiec TC; Trusley C; Trissel LA
Int J Pharm Compd; 2008; 12(5):460-2. PubMed ID: 23969872
[TBL] [Abstract][Full Text] [Related]
5. Compatibility and stability of palonosetron hydrochloride and propofol during simulated y-site administration.
Trissel LA; Trusley C; Kupiec TC; Ben M
Int J Pharm Compd; 2009; 13(1):78-80. PubMed ID: 23969967
[TBL] [Abstract][Full Text] [Related]
6. Physical and chemical stability of palonosetron hydrochloride with Fluorouracil and with gemcitabine hydrochloride during simulated y-site administration.
Trissel LA; Zhang Y
Int J Pharm Compd; 2005; 9(4):320-2. PubMed ID: 23925056
[TBL] [Abstract][Full Text] [Related]
7. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration.
Ben M; Trusley C; Kupiec TC; Trissel LA
Int J Pharm Compd; 2008; 12(4):368-71. PubMed ID: 23969774
[TBL] [Abstract][Full Text] [Related]
8. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Trissel LA; Zhang Y
Ann Pharmacother; 2005 Feb; 39(2):280-3. PubMed ID: 15613463
[TBL] [Abstract][Full Text] [Related]
9. Physical and chemical stability of palonosetron hydrochloride with Lorazepam and midazolam hydrochloride during simulated y-site administration.
Trissel LA; Xu QA
Int J Pharm Compd; 2005; 9(3):235-7. PubMed ID: 23924982
[TBL] [Abstract][Full Text] [Related]
10. Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated y-site administration.
Trissel LA; Xu QA
Int J Pharm Compd; 2005; 9(3):238-41. PubMed ID: 23924983
[TBL] [Abstract][Full Text] [Related]
11. Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated y-site administration.
Trusley C; Ben M; Kupiec TC; Trissel LA
Int J Pharm Compd; 2007; 11(1):82-5. PubMed ID: 23974489
[TBL] [Abstract][Full Text] [Related]
12. Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupie TC; Trusley C; Ben M; Trissel LA
Am J Health Syst Pharm; 2008 Sep; 65(18):1735-59. PubMed ID: 18769000
[TBL] [Abstract][Full Text] [Related]
13. Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated y-site administration.
Trissel LA; Zhang Y; Xu QA
Int J Pharm Compd; 2006; 10(3):234-6. PubMed ID: 23974237
[TBL] [Abstract][Full Text] [Related]
14. Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during simulated Y-site administration.
Trissel LA; Trusley C; Ben M; Kupiec TC
Am J Health Syst Pharm; 2007 Jun; 64(11):1209-13. PubMed ID: 17519464
[TBL] [Abstract][Full Text] [Related]
15. Physical and chemical stability of palonosetron HCl in 4 infusion solutions.
Trissel LA; Xu QA
Ann Pharmacother; 2004 Oct; 38(10):1608-11. PubMed ID: 15328393
[TBL] [Abstract][Full Text] [Related]
16. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
Wu G; Powers D; Yeung S; Chen F
Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388
[TBL] [Abstract][Full Text] [Related]
17. Compatibility of palonosetron with cyclophosphamide and with ifosfamide during simulated Y-site administration.
Xu QA; Trissel LA
Am J Health Syst Pharm; 2005 Oct; 62(19):1998-2000. PubMed ID: 16174835
[TBL] [Abstract][Full Text] [Related]
18. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
Wu G; Yeung S; Chen F
Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
[TBL] [Abstract][Full Text] [Related]
19. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.
Wu G; Powers D; Yeung S; Chen F; Neelon K
Int J Pharm Compd; 2018; 22(1):86-94. PubMed ID: 29385389
[TBL] [Abstract][Full Text] [Related]
20. Compatibility and stability of aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
Trissel LA; Zhang Y
Int J Pharm Compd; 2004; 8(5):398-403. PubMed ID: 23924770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
